The cell-free system of clinical isolates of drug-resistant Staphylococcus aureus inactivated kanamycin, and the inactivated product was identified withkanamycin-3'-phosphate, in which the C-3-OH of the 6-amino-6-deoxy-D-glucose moiety of kanamycin was phosphorylated.
The cell-free system of clinical isolates of drug-resistant Staphylococcus aureus inactivated kanamycin, and the inactivated product was identified withkanamycin-3'-phosphate, in which the C-3-OH of the 6-amino-6-deoxy-D-glucose moiety of kanamycin was phosphorylated.
Acetylation of chloramphenicol by enzymes of drug-resistant Escherichia coli and Staphylococcus aureus (3, 4, 6, 7) and phosphorylation or acetylation of kanamycin by enzymes of drugresistant E. coli carrying R factor (2, 5, 8, 9) , resulting in inactivation of these antibiotics, have been reported. As reported in an accompanying paper, Pseudomonas aeruginosa also produced an enzyme capable of phosphorylating and inactivating kanamycin (1). The investigation was extended to study the mode of the resistance of drug-resistant clinical isolates of S. aureus to kanamycin, and the results are presented in this paper. It was observed that the cell-free system of drug-resistant S. aureus inactivated kanamycin, phosphorylating kanamycin to kanamycin-3'-phosphate, which was identical with that phosphorylated by E. coli carrying R factor or P. aeruginosa. Preparation of the cell-free system of S. aureus. Strains B294 and B295 were grown in 0.3% glucose broth at 37 C. The cells were harvested at the logarithmic phase of growth (3- Inactivation ofkanamycin. The reaction mixture for inactivation of kanamycin consisted of: S. aureus B294 extracts, 2.5 mg of protein per ml; kanamycin sulfate, 2 mM; adenosine triphosphate (ATP)-2 Na, 20 mM; MgCI2, 10 mM; KCI, 60 mm; and Tris-chloride, 100 mm, pH 7.0. It was incubated at 37 C for 20 hr. Thereafter, it was heated at 80 C for 5 min and centrifuged. The activity of the residual antibiotic was determined by a disc-agar plate method, using Bacillus subtilis PCI 219 as a test organism.
Purification procedure of inactivated kanamycin. After the reaction, the reaction mixture in which 80 mg of kanamycin was inactivated was centrifuged, and the supernatant fluid (100 ml) was passed through a column (140 ml) of Amberlite IRC-50 (Na+ form). After washing with distilled water, 1% NH4OH was used as eluant. The ninhydrin-positive fractions were collected and dried in vacuo. The crude powder (138 mg) thus obtained was dissolved in water and subjected to column chromatography on Dowex 1 X 8 resin (70 ml, OH-form), washed with water, and eluted with 1.5 N H2SO4. The eluate was neutralized and the ninhydrin-positive fractions were collected. It was passed through a Sephadex G-10 column (10 ml) to remove Na2SO4 and Tris buffer. The ninhydrin-positive eluate was concentrated in vacuo and dried, yielding 42 mg of a light brown powder. It was further purified by column chromatography on Amberlite CG-50 resin (50 ml, NH4+ form). After washing with distilled water, 1% NH4OH was used as eluant. The ninhydrin-positive fraction was concentrated in vacuo and dried, yielding 33 mg of the inactivated kanamycin.
RESULTS AND DIscussIoN
Extracts of strains B294 and B295 of drugresistant S. aureus were observed to contain an enzyme inactivating kanamycin in the presence of ATP. The inactivation occurred in the reaction mixture consisting of: S. aureus B294 extracts (2 mg of protein per ml); coenzyme A, 0.04 mM; creatine phosphate, 4 mM; creatine phosphoki- nase, 60 ,ug/ml; ATP, 10 mM; KCI, 60 mM; Mg acetate, 10 mM; Tris-chloride (pH 7.8), 100 mM at 37 C for 4 hr. In this reaction mixture, kanamycin, chloramphenicol, neomycin, and benzylpenicillin were inactivated, but tetracycline and streptomycin were not inactivated ( Table 1) .
The time course of inactivation of kanamycin by drug-resistant S. aureus extract in the presence of ATP was studied (Fig. 1) . Kanamycin, at 0.2 mM, was more rapidly inactivated than at 2 mm.
The optimal pH for the inactivation of kanamycin by S. aureus B294 was approximately 7.0 to 7.5 (Fig. 2) . It is interesting that the optimal pH of the kanamycin inactivation is almost the same among inactivating enzymes of E. coli carrying R factor, Pseudomonas, and S. aureus.
The inactivated kanamycin was isolated by cation exchange resin processes. It showed the following properties, darkening at 255 to 260 C but not melting at 300 C. Analysis-C18H35N4011-PO(OH)2.2H20; calculated: C, 36.00; H, 6. 
